SRNE
Sorrento Therapeutics, Inc.
Set alert
0.00 USD 0.00 0.00%
0.009 Day range 0.01
0.0001 52-week range 0.016
- YTD
- -88.46%
- 1 year
- -95.45%
- Open
- 0.009
- Prev close
- 0.0003
- Mkt cap
- 165.38K
- Vol
- 501.68K
- Avg vol
- 80.52K
- EPS
- -0.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.009
- High
- 0.01
- Forward P/E
- -0.45
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 4, 2024
- 50-d avg
- 0.817524
- 200-d avg
- 1.58
- 1y target
- 13.00
Key statistics
- Market cap
- 168.36M
- Trailing P/E
- 0.00
- Forward P/E
- -0.45
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.817524
- 200-day average
- 1.58
Analyst view
Consensus: buy
Buy
Price target (mean) 13.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Oct 4, 2024
Expected Oct 4, 2024. Consensus EPS estimate -0.19.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 4, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Feb 28, 2023 | Dec 1, 2022 | -0.19 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -0.25 | -0.20 | +0.05 | +20.00% |
| Aug 15, 2022 | Jun 1, 2022 | -0.23 | -0.31 | -0.08 | -34.78% |
| May 5, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2022 | Cantor Fitzgerald | init | — | Overweight |
| Mar 25, 2022 | HC Wainwright & Co. | main | — | Buy |
| Aug 9, 2021 | HC Wainwright & Co. | main | — | Buy |
| Jan 21, 2021 | Alliance Global Partners | init | — | Buy |
| Jul 31, 2020 | HC Wainwright & Co. | main | — | Buy |
| May 26, 2020 | Dawson James | init | — | Buy |
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SRNE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABG MANAGEMENT, LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 12, 2018 | 0 |
| ASGHAR NAJJAM | Chief Financial Officer | Stock Award(Grant) | Mar 15, 2021 | 56,974 |
| ASIA PACIFIC MEDTECH BVI, LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 23, 2018 | 8,617,510 |
| FOLLOWWILL DORMAN | Director | Sale | Dec 15, 2020 | 2,130 |
| JANDA KIM D | Director | Sale | Dec 26, 2021 | 3,000 |
| JI HENRY H | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 20, 2022 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| State Street Corporation | 10.73% | 50,637,571 | 15.56M | Dec 30, 2022 |
| Blackrock Inc. | 8.35% | 39,423,641 | 12.11M | Dec 30, 2022 |
| Vanguard Group, Inc. (The) | 6.26% | 29,535,954 | 9.08M | Dec 30, 2022 |
| Geode Capital Management, LLC | 1.89% | 8,905,936 | 2.74M | Dec 30, 2022 |
| B. Riley Financial, Inc. | 1.11% | 5,216,250 | 1.60M | Dec 30, 2022 |
| B. Riley Securities, Inc. | 1.11% | 5,216,250 | 1.60M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 8.66% | 40,885,070 | 12.56M | Dec 30, 2022 |
| Vanguard Total Stock Market Index Fund | 2.72% | 12,843,725 | 3.95M | Sep 29, 2022 |
| iShares Russell 2000 ETF | 2.20% | 10,359,426 | 3.18M | Dec 30, 2022 |
| Vanguard Extended Market Index Fund | 1.17% | 5,513,243 | 1.69M | Sep 29, 2022 |
| Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 0.91% | 4,270,781 | 1.31M | Dec 30, 2022 |
| iShares Russell 2000 Value ETF | 0.87% | 4,113,608 | 1.26M | Dec 30, 2022 |